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rigorous qualitative research. This approach combines grounded
theory methods and is underpinned by an overarching phenom-
enological framework. It is used to develop PRO items and scales
that possess content validity and the ability to yield a measure-
ment model for psychometric testing. This paper will present: 1)
The rationale for the combination of these two schools of quali-
tative research; 2) the current tools that are used that include
semi-structured interviews, a computerized software package,
theoretical sampling, saturation and grounded theory data analy-
sis methods; 3) examples of successful application of qualitative
research to PRO development; and 4) future applications of
qualitative research in upcoming/planned clinical trials.
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OBJECTIVES: In children, utility and health-related quality of
life (HRQOL) measurements may be inﬂuenced by age, cognitive
ability and disease severity. Parents are often proxy respondents.
The objectives were to assess the validity and reliability of a
parent-child dyad utility and HRQOL assessment wherein chil-
dren and parents are interviewed together to assess the child’s
HRQOL. METHODS: The Health Utility Index (HUI), PedsQL
Core and Asthma Modules and the Pediatric Asthma Quality of
Life Questionnaire (PAQLQ) were administered to 93 asthmatic
children aged 8 to 15 years and their parents in a joint dyad
interview. All questions were directed at the child to assess the
child’s utility and HRQOL. Questionnaires were scored nor-
mally. A pre-tested structured guide was available to interview-
ers. To assess construct validity of the dyad approach, Spearman
correlations were calculated between HUI attributes and ques-
tionnaire domains associated with physical function and with
emotional function. Test-retest reliability was assessed with an
intra-class correlation coefﬁcient (ICC) in 28 children who
remained clinically stable between baseline and follow-up assess-
ments at 5 months. RESULTS: Among the parent-child dyads,
the HUI2 Mobility attribute was signiﬁcantly correlated
(p < 0.05) with the PedsQL Core Physical (r = 0.41) and the
PAQLQ Activities (r = 0.32) domains. The HUI2 Emotion
attribute was signiﬁcantly correlated (p < 0.05) with the PedsQL
Core Emotion (r = 0.39), the PedsQL Core Social (r = 0.34), the
PedsQL Asthma Communication (r = 0.21) and the PAQLQ
Emotion (r = 0.25) domains. For clinically stable children, sig-
niﬁcant ICCs between baseline and follow-up were observed for
the HUI2 Total (r = 0.53), PedsQL Core Total (r = 0.70), PedsQL
Asthma Symptoms (r = 0.84), PedsQL Asthma Treatment
(r = 0.51), PAQLQ Activity (r = 0.75) and PAQLQ Emotion
(r = 0.76) domains. CONCLUSIONS: The parent-child dyad
demonstrated moderate construct validity and moderate to
strong test-retest reliability in generic and disease-speciﬁc ques-
tionnaires. This approach may be a valid alternative to relying on
parent proxies for assessing children’s utility and HRQOL.
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The multi-attribute health status (MAHS) approach to develop-
ing indirect utility measures assumes that health preferences are
formed from the simultaneous consideration of multiple health
dimensions. We propose an alternative view that theorizes the
formation of health preferences is mediated by global impres-
sions of quality of life (QL). This study compared the theory of
global health preference formation (GHPF) with the MAHS
approach for explaining time trade-off utilities. A total of 1432
cancer patients completed the EORTC QLQ-C30 and valued
their own current health. A mediation analysis was performed
using latent variable models relating health preferences to QLQ-
C30 domains. Founded on the MAHS approach, Model I
described health preferences using the physical, role, cognitive,
emotional, and social functioning domains (PF, RF, CF, EF, and
SF, respectively) and the fatigue (FA), pain (PA), and nausea/
vomiting (NV) symptom domains. Model II related the QL
domain to the same functioning and symptom domains. Consis-
tent with the GHPF framework, Model III purported that QL
mediated associations of health preferences with functioning
and symptoms. Ignoring QL, health preferences were related
to PF (b = 0.041/p = 0.050), SF (b = 0.057/p = 0.028), and
EF (b = -0.054/p = 0.001). Model II: QL was positively related
to RF (b = 0.222/p = 0.001), EF (b = 0.116/p = 0.001), SF
(b = 0.257/p < 0.001), FA (b = 0.245/p < 0.001), and PA
(b = 0.123/p = 0.001). Model III: QL was positively related to
health preferences (b = 0.117/p < 0.001). Controlling for QL, the
only functioning or symptom domain related to health prefer-
ences was EF (b = -0.067/p < 0.001). Signiﬁcant indirect effects
representing differences between direct effect estimates for
Models I and III were observed for RF (b = 0.026/p = 0.001), EF
(b = 0.014/p = 0.002), SF (b = 0.030/p < 0.001), FA (b = 0.029/
p = 0.003), and PA (b = 0.014/p = 0.002). Model III provided a
signiﬁcantly better ﬁt than Model I (p < 0.001). The MAHS
approach yields misspeciﬁed models of health preferences since
QL mediates associations of the latter with functioning and
symptoms. Our framework has far-reaching implications for
utility assessment and warrants further research.
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OBJECTIVE: More than one-third of patients with diabetes
exhibit poor adherence with recommended drug regimens. While
poor adherence is associated with excess morbidity and mortal-
ity, it is important to realize that better adherence may also affect
short-term health care costs. This research quantiﬁes the effects
of improvements in medication adherence on short-term health
services utilization and their associated costs. METHODS: Data
from Florida: A Healthy State (FAHS), a Medicaid disease man-
agement program developed jointly by Pﬁzer Inc. and the state of
Florida targeting chronically ill Primary Care Case Management
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Program beneﬁciaries. The sample contains 5000 diabetes
patients who were continuously eligible for Medicaid beneﬁt
and FAHS for at least 2 years. Medication adherence was mea-
sured with the Medication Possession Ratio (MPR) for
diabetes-speciﬁc prescriptions, statins, and ACEs/ARBs. MPR
was calculated separately for the ﬁrst 12 months (baseline) and
the following 12 months (follow-up). Costs were similarly
summed over the 12 month intervals of baseline and follow-up.
Estimation was performed with ﬁrst-difference and conditional
logistic regressions. RESULTS: Improvement in MPR between
baseline and follow-up was reﬂected in lower inpatient, emer-
gency room (ER), and total non-drug costs. A 10% improve-
ment in MPR for hypoglycemic medications reduced inpatient
costs by $127.97 (p = 0.002), ER costs by $3.72 (p = 0.003),
and total non-drug costs by $116.00 (p = 0.009) over 12
months. This reduction in inpatient costs was the result of a
shorter average length of stay: a decrease of 0.2 (p = 0.03) day
per 10% increase in MPR. Finally, a 10% improvement in
adherence with statins reduced the probability of being hospi-
talized by 4.3% (p = 0.01). CONCLUSION: This research
demonstrates the existence of signiﬁcant short-term savings
related to the improvement of medication adherence among
persons with diabetes.
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OBJECTIVE: The failure to maintain adherence to recom-
mended medication and testing regimens is associated with
excess morbidity and mortality among diabetics. This presenta-
tion focuses on the adherence patterns of diabetics enrolled in
Florida: A Healthy State (FAHS), a Medicaid disease manage-
ment program. METHODS: Attention is given to the baseline
characteristics of program participants, and the association
between them and baseline adherence to hypoglycemic agents,
ACEI, ARB, Statins, and annual tests (HbA1C, lipids, microal-
bumin, retinal exam). A matched-group comparison examined
changes in patterns of medication and test adherence at
follow-up for those enrolled in the nurse care management
module. RESULTS: A total of 8432 diabetic adults were continu-
ously enrolled for 24 months. Multivariate models evaluating
their baseline adherence to hypoglycemics, ACEI, ARB, Statins
and recommended tests were ﬁt. Those who were adherent to one
class of diabetes-related medication were 1.5 to 3.5 times more
likely to be adherent to another class of diabetes-related medi-
cation. Baseline adherence to recommended tests was associated
with 50% greater odds of adherence to hypoglycemics, ACEI and
Statin. The proﬁle of the 2597 (31%) moderate and high risk
participants that enrolled in the nurse care management module
was signiﬁcantly different than that of non-enrollees. Participants
had more comorbidities, greater service utilization and costs, and
lower medication and test adherence. In a matched-group com-
parison, nurse care management was associated with improved
odds of: ﬁlling at least one script during the study period among
those who were not using diabetes medications at baseline,
adherence to insulin among those using diabetes medications at
baseline, and adherence to recommended testing CONCLU-
SION: A pattern of overall adherence behavior was observed at
baseline. Participation in nurse care management improved
adherence to recommended diabetes medication and testing regi-
mens. It is believed that these results can be generalized to other
Medicaid populations.
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OBJECTIVE: The effect of insomnia along with the decreased
cognitive functioning associated with aging is a serious concern
within the elderly (65 years and older) population. We examined
the association of patient health care utilization and depressive
symtomatology with medication adherence in insomnia in
Medicare-HMO enrolled elderly patients. METHODS: This was
a retrospective, longitudinal cohort study which included elderly
patients (65 and older) enrolled continuously for 1–5 years in the
Medicare HMO. Medication possession ratio was used to esti-
mate the adherence in insomnia medication. Different MPR
thresholds (0.8, 0.6, 0.4 and 0.2) were used to determine non
adherence. Associations between depressive symptoms, medica-
tion adherence and health care costs were assessed using ordinary
least square multiple regressions. RESULTS: A total of 2068
patients with a primary diagnosis of insomnia were included in
the study. Sixty percent of these patients had depressive symp-
tomatology. The severity of comorbidity (Charlson index) was 4
and the patient perception of quality of life (Short Form-12
scores) were between 79 and 82. The prevalence of non adher-
ence was 70% even with a low MPR of 0.2. Insomnia patients
with depressive symptoms were 92% less likely to be adherent to
their insomnia medications (p < 0.05). After controlling other
variables, we found MPR was a good predictor of total health
care costs (10% increases in MPR for every 2% decrease in total
health care costs, p < 0.001). CONCLUSION: We found strong
associations between depressive symtomatology, medication
adherence, and health care costs in elderly patients with insom-
nia. Disease and risk management programs in managed care
settings should be used to optimize the medication adherence in
the elderly.
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OBJECTIVE: Investigate the effects of non-adherence by pro-
viders to the National Institutes of Health treatment guidelines
on the costs of care for children and adults with asthma. The
Guidelines recommend providing access to rescue medications
but restricting their overuse through controller medications.
METHODS: Pediatric (6–19 years) and adult (20–64 years)
patients with a prescription for an albuterol inhaler (AI) or an
inhaled corticosteroid (ICS) and a diagnosis for asthma between
January 1, 2001 and December 31, 2005 were identiﬁed from the
Utah Medicaid population. Patients were observed for ninety
days following the ﬁrst prescription and classiﬁed into three
groups on the basis of AI use and ICS prescription, as following:
1) less than three canisters of AI (appropriate); 2) three or more
canisters of AI (inappropriate); 3) no AI use but a prescription for
ICS (inappropriate). Once categorized as adherent (group 1) or
non-adherent (groups 2, 3), direct medical costs were estimated
for children and adults for one year using generalized linear
two-part regression models adjusting for demographics, comor-
bidities, smoking status, seasonal effects and year. RESULTS:
Of the ﬁnal sample (N = 4751), children comprised 40.4%
Abstracts A15
